Advenchen Pharmaceuticals, Llc.

This study is testing a new oral medication called AL8326 for people with recurrent small cell lung cancer who need a second or later line of treatment. The main goals are to find the safest and most effective dose and to see if the drug helps shrink tumors. The trial will involv…